Vistagen Therap (VTGN.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov14

Vistagen Therap released FY2026 Q2 earnings on November 13 After-Market (EST), actual revenue USD 258K (forecast USD 145.8K), actual EPS USD -0.5431 (forecast USD -0.476)

00:00

Vistagen Therap released FY2026 Semi-Annual earnings on November 13 After-Market EST, actual revenue USD 502K, actual EPS USD -1.0195

00:00

Nov6

Vistagen Therap to release FY2026 Q2 earnings on November 13 After-Market EST, forecast revenue USD 145.8 K, EPS USD -0.476

00:06

Oct29

Analyst Minter Gives VistaGen a Strong Buy Rating

10:42

Aug7

Vistagen Therap released FY2026 Q1 earnings on August 7 After-Market (EST), actual revenue USD 244K (forecast USD 215.67K), actual EPS USD -0.4727 (forecast USD -0.4733)

23:00

Jul31

Vistagen Therap to release FY2026 Q1 earnings on August 7, 2025, After-Market EST, with forecasted revenue of USD 215.67 K and EPS of USD -0.4733

00:09